.
Select language to translate
Envision Scientific is an organization involved in Research and Development activities in the field of advanced cardiovascular devices. The company has developed various technological superior devices and drug delivery systems which increase levels of safety and effectiveness of treatments.
Visit us at Euro PCR 2013 : Booth M14 at Paris. 21st to 24th May 2013
NANO ACTIVE COATING TECHNOLOGY
Nanoactive Coating technology is a development of Envision for coating of cardiology medical devices. The Coating technology is based on nano carrier preparation concept of drugs to be delivered. The specific method of carrier preparation and coating device has been patented by the company.
Nanoactive Coating technology is a development of Envision for coating of cardiology medical devices. The Coating technology is based on nano carrier preparation concept of drugs to be delivered. The specific method of carrier preparation and coating device has been patented by the company.
ABLUMINUS DRUG ELUTING STENT SYSTEM
Abluminus drug eluting stent system is a Sirolimus based drug eluting stent from a bio-degradable polymer matrix. Specific coating process of a crimped stent is done with only abluminal surface coated. The stent is a chromium cobalt platform with a hybrid design making it highly deliverable in difficult lesions.
Abluminus drug eluting stent system is a Sirolimus based drug eluting stent from a bio-degradable polymer matrix. Specific coating process of a crimped stent is done with only abluminal surface coated. The stent is a chromium cobalt platform with a hybrid design making it highly deliverable in difficult lesions.
FOCUS NP NANOCARRIER ELUTING STENT SYSTEM
FOCUS np is the next generation of drug eluting stent designed using novel principles of Nanotechnology. The unique coating process has dual release – acute drug delivery from Balloon and Stent surface on deployment and long term drug release from the surface of the stent. It converts to bare metal stent at 6 ~ 8 months.
FOCUS np is the next generation of drug eluting stent designed using novel principles of Nanotechnology. The unique coating process has dual release – acute drug delivery from Balloon and Stent surface on deployment and long term drug release from the surface of the stent. It converts to bare metal stent at 6 ~ 8 months.
PCR 2010, Paris FRANCE : Envision Scientific selected to present its novel NANOACTIVE (Nanocarrier based drug delivery) Technology in Innovation Arena. The technology generates keen interest from the Scientific Community as it is the first to delivery drug in polymer free encapsulated matrix.
Manish Doshi
CEO, Envision Scientific
CRT 2012, Miami USA : Envision Scientific’s FOCUS np Technology presented at Cardiovasculer Resarch Technologies Meeting by Prof. Patrick Serruys- Thoraxcenter, Rotterdam, The Netherlands.
Manish Doshi
CEO, Envision Scientific
TCT 2012, Miami USA : Envision Scientific presents its first update on NANOACTIVE FIM-IN Clinical study with FOCUS np Nanocarrier based coronary stent system. The Presentation was done by Dr. Ashok Seth - Principal Investigator, Fortis Escorts Heart Institute, New Delhi.
Manish Doshi
CEO, Envision Scientific
